COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease

American Journal of Chinese Medicine

Volumn 48, Issue 3, 2020, Pages 737-762

  Chan, Kam Wa ^a   Wong, Vivian Taam ^b   Tang, Sydney Chi Wai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

2019 nCoV; Chinese Medicine; COVID 19; Guideline; Integrative Medicine; Review

Indexed keywords

ARBIDOL; BA BAO DAN CAPSULE; CHINESE DRUG; COBICISTAT; DA YUAN DECOCTION; DARUNAVIR; FAVIPIRAVIR; FINGOLIMOD; GLUCOCORTICOID; HONEYSUCKLE DECOCTION; HUA TAN ZHI KE GRANULE; HUO PU XIA LING DECOCTION; HUO XIANG ZHENG QI POWDER; JING YE BAI DU GRANULE; KANG BING DU GRANULE; KE SU TING SYRUP; LEFLUNOMIDE; LIAN HUA QING WEN CAPSULE; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; QING FEI PAI DU DECOCTION; REMDESIVIR; RIAMILOVIR; SHENG JIANG POWDER; SHUANG HUANG LIAN; TAN RE QING INJECTION; TOCILIZUMAB; TRANILAST; UNCLASSIFIED DRUG; UNINDEXED DRUG; XUE BI JING INJECTION;

2009 H1N1 INFLUENZA; ALLOPATHY; ARTICLE; CHINESE MEDICINE; CLINICAL FEATURE; COMPUTER MODEL; CORONAVIRUS DISEASE 2019; EVIDENCE BASED PRACTICE; HUMAN; INTEGRATIVE MEDICINE; PRACTICE GUIDELINE; QIGONG; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; WESTERN MEDICINE; BETACORONAVIRUS; CLINICAL TRIAL (TOPIC); CORONAVIRUS INFECTION; PANDEMIC; PATHOLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; CLINICAL TRIALS AS TOPIC; CORONAVIRUS INFECTIONS; HUMANS; INTEGRATIVE MEDICINE; MEDICINE, CHINESE TRADITIONAL; PANDEMICS; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC;

EID: 85082179878     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X20500378     Document Type: Article

References (119)

1. Arabi, Y.M., Y. Mandourah, F. Al-Hameed, A.A. Sindi, G.A. Almekhlafi, M.A. Hussein, J. Jose, R. Pinto, A. Al-Omari, A. Kharaba, A. Almotairi, K. Al Khatib, B. Alraddadi, S. Shalhoub, A. Abdulmomen, I. Qushmaq, A. Mady, O. Solaiman, A.M. Al-Aithan, R. Al-Raddadi, A. Ragab, H.H. Balkhy, A. Al Harthy, A.M. Deeb, H. Al Mutairi, A. Al-Dawood, L. Merson, F.G. Hayden and R.A. Fowler. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am. J. Respir. Crit. Care Med. 197: 757-767, 2018.
2. Bernheim, A., X. Mei, M. Huang, Y. Yang, Z.A. Fayad, N. Zhang, K. Diao, B. Lin, X. Zhu, K. Li, S. Li, H. Shan, A. Jacobi and M. Chung. Chest CT findings in Coronavirus Disease-19 (COVID-19): Relationship to duration of infection. Radiology 395: 514-523, 2020.
3. Booth, C.M., L.M. Matukas, G.A. Tomlinson, A.R. Rachlis, D.B. Rose, H.A. Dwosh, S.L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I.E. Ephtimios, I. Kitai, B.D. Mederski, S.B. Shadowitz, W.L. Gold, L.A. Hawryluck, E. Rea, J.S. Chenkin, D.W. Cescon, S.M. Poutanen and A.S. Detsky. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289: 2801-2809, 2003.
4. Chan, J.W., C.K. Ng, Y.H. Chan, T.Y. Mok, S. Lee, S.Y. Chu, W.L. Law, M.P. Lee and P.C. Li. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 58: 686-689, 2003a.
5. Chan, K.S., S.T. Lai, C.M. Chu, E. Tsui, C.Y. Tam, M.M. Wong, M.W. Tse, T.L. Que, J.S. Peiris, J. Sung, V.C. Wong and K.Y. Yuen. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: A multicentre retrospective matched cohort study. Hong Kong Med. J. 9: 399-406, 2003b.
6. Chan, J.F., K.H. Kok, Z. Zhu, H. Chu, K.K. To, S. Yuan and K.Y. Yuen. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9: 221-236, 2020a.
7. Chan, J.F., S. Yuan, K.H. Kok, K.K. To, H. Chu, J. Yang, F. Xing, J. Liu, C.C. Yip, R.W. Poon, H.W. Tsoi, S.K. Lo, K.H. Chan, V.K. Poon, W.M. Chan, J.D. Ip, J.P. Cai, V.C. Cheng, H. Chen, C.K. Hui and K.Y. Yuen. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 395: 514-523, 2020b.
8. Chang, M. Lin, L. Wei, L. Xie, G. Zhu, C.S. Dela Cruz and L. Sharma. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA, 2020, doi:10.1001/jama.2020.1623.
9. Chen, H. and Q. Du. Potential natural compounds for preventing 2019-nCoV infection. Preprints 2020010358: 2020.
10. Chen, N., M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei, J. Xia, T. Yu, X. Zhang and L. Zhang. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395: 507-513, 2020a.
11. Chen, Z., Y. Bian, Y. Yang, Y. Shu, R. Tong, J. Yan, L. He, E. Long and M. Chen. Rational use of Chinese patent medicines for pneumonia caused by novel coronavirus. Herald Med., 2020b, https://kns8.cnki.net/KCMS/detail/42.1293.R.20200210.2004.004.html.
12. Cheng, D. and Y. Li. Clinical effectiveness and case analysis in 54 NCP patients treated with Lanhuaqingwen granules. World Chin. Med. 15: 150-154, 2020.
13. Choi, K.W., T.N. Chau, O. Tsang, E. Tso, M.C. Chiu, W.L. Tong, P.O. Lee, T.K. Ng, W.F. Ng, K.C. Lee, W. Lam, W.C. Yu, J.Y. Lai and S.T. Lai. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann. Intern. Med. 139: 715-723, 2003.
14. Chu, C.M., V.C. Cheng, I.F. Hung, M.M. Wong, K.H. Chan, K.S. Chan, R.Y. Kao, L.L. Poon, C.L. Wong, Y. Guan, J.S. Peiris and K.Y. Yuen. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59: 252-256, 2004.
15. Dai, M., G. Xiao, Y. Wang, L. Li, Y. Yang, H. Xie, Y. Li, W. Wang, Y. Wu, Y. Hu and H. Yang. Preliminary analysis of clinical manifestations of Lingnan new coronavirus pneumonia. Tianjin J. Tradit. Chin. Med. 37: 132-136, 2020.
16. Del Rio, C. and P.N. Malani. 2019 novel coronavirus-important information for clinicians. JAMA, 2020, doi:10.1001/jama.2020.1490.
17. Dong, E., H. Du and L. Gardner. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis., 2020, doi:10.1016/S1473-3099(20)30120-1.
18. Fan, Y., Y. Wang, H. Zhang and Y. Wang. Analysis on the treatment of pneumonia infected by new coronavirus (2019-nCoV) from the cold epidemic. J. Tradit. Chin. Med., 2020.
19. Gao, S., Y. Ma, F. Yang, J. Zhang and C. Yu. Zhang. ZHANG Boli: Traditional Chinese medicine plays a role in the prevention and treatment on novel coronavirus pneumonia. Tianjin J. Tradit. Chin. Med. 37: 121-124, 2020.
20. Gilbert, M., G. Pullano, F. Pinotti, E. Valdano, C. Poletto, P.-Y. Boëlle, E. D'Ortenzio, Y. Yazdanpanah, S.P. Eholie, M. Altmann, B. Gutierrez, M.U.G. Kraemer and V. Colizza. Preparedness and vulnerability of African countries against importations of COVID-19: A modelling study. Lancet, 2020, doi:10.1016/S0140-6736(20)30411-6.
21. GISAID Initiative. Genomic epidemiology of BetaCoV 2019-2020. 2020. GitHub. 2019 novel coronavirus COVID-19 (2019-nCoV) data repository by Johns Hopkins CSSE. USA, 2020.
22. Guan, W.-J., Z.-Y. Ni, Y. Hu, W.-H. Liang, C.-Q. Ou, J.-X. He, L. Liu, H. Shan, C.-L. Lei, D.S. Hui, B. Du, L.-J. Li, G. Zeng, K.-Y. Yuen, R.-C. Chen, C.-L. Tang, T. Wang, P.-Y. Chen, J. Xiang, S.-Y. Li, J.-L. Wang, Z.-J. Liang, Y.-X. Peng, L. Wei, Y. Liu, Y.-H. Hu, P. Peng, J.-M. Wang, J.-Y. Liu, Z. Chen, G. Li, Z.-J. Zheng, S.-Q. Qiu, J. Luo, C.-J. Ye, S.-Y. Zhu and N.-S. Zhong. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020.2002.2006.20020974, 2020.
23. Guangdong Medical Products Administration. Notice on the clinical use of Tongjie Quwen Granules (formerly known as pneumonia No. 1). Guangdong Medical Products Administration, Guangdong, 2020.
24. Guo, Z. Remdesivir: From compassionate medication to phase III clinical study. Acta Pharmaceutica Sinica, 2020, https://kns8.cnki.net/KCMS/detail/11.2163.r.20200211.1017.002.html. Healthmap. HealthMap of the Coronavirus Outbreak. 2020.
25. Heymann, D.L. and N. Shindo. COVID-19: What is next for public health? Lancet 395: 542-545, 2020.
26. Ho, J.C., G.C. Ooi, T.Y. Mok, J.W. Chan, I. Hung, B. Lam, P.C. Wong, P.C. Li, P.L. Ho, W.K. Lam, C.K. Ng, M.S. Ip, K.N. Lai, M. Chan-Yeung and K.W. Tsang. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 168: 1449-1456, 2003.
27. Hoehl, S., A. Berger, M. Kortenbusch, J. Cinatl, D. Bojkova, H. Rabenau, P. Behrens, B. Boddinghaus, U. Gotsch, F. Naujoks, P. Neumann, J. Schork, P. Tiarks-Jungk, A. Walczok, M. Eickmann, M. Vehreschild, G. Kann, T. Wolf, R. Gottschalk and S. Ciesek. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N. Engl. J. Med., 2020, doi:10.1056/NEJMc2001899.
28. Holshue, M.L., C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, C. Spitters, K. Ericson, S. Wilkerson, A. Tural, G. Diaz, A. Cohn, L. Fox, A. Patel, S.I. Gerber, L. Kim, S. Tong, X. Lu, S. Lindstrom, M.A. Pallansch, W.C. Weldon, H.M. Biggs, T.M. Uyeki and S.K. Pillai. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 382: 929-936, 2020.
29. Hu, M., R. Dong, G. Chen, H. Dong, M. Zhang, F. Lu and S. Tu. A case of severe new coronavirus pneumonia treated by integrated traditional Chinese and Western medicine. Chin. J. Integr. Tradit. West. Med., 2020, doi:10.7661/j.cjim.20200204.065.
30. Huang, K.J., I.J. Su, M. Theron, Y.C. Wu, S.K. Lai, C.C. Liu and H.Y. Lei. An interferon-gammarelated cytokine storm in SARS patients. J. Med. Virol. 75: 185-194, 2005.
31. Huang, C., Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang and B. Cao. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497-506, 2020.
32. Idborg, H. Symptom-based stratification of autoimmune diseases. Lancet Rheumatology 1: e76-e77, 2019.
33. Jiang, Q., J. Lang, P. Guo, Q. Jiang, H. Xiao and M. Feng. Comparison of diagnosis and treatment scheme of pneumonia with 2019-novel coronavirus infection in China on Evidence-based Medicine. West China J. Pharm. Sci., 2020, https://kns8.cnki.net/KCMS/detail/51.1218.R.20200210.1130.002.html.
34. Jin, Y.H., L. Cai, Z.S. Cheng, H. Cheng, T. Deng, Y.P. Fan, C. Fang, D. Huang, L.Q. Huang, Q. Huang, Y. Han, B. Hu, F. Hu, B.H. Li, Y.R. Li, K. Liang, L.K. Lin, L.S. Luo, J. Ma, L.L. Ma, Z.Y. Peng, Y.B. Pan, Z.Y. Pan, X.Q. Ren, H.M. Sun, Y. Wang, Y.Y. Wang, H. Weng, C.J. Wei, D.F. Wu, J. Xia, Y. Xiong, H.B. Xu, X.M. Yao, Y.F. Yuan, T.S. Ye, X.C. Zhang, Y.W. Zhang, Y.G. Zhang, H.M. Zhang, Y. Zhao, M.J. Zhao, H. Zi, X.T. Zeng, Y.Y. Wang and X.H. Wang. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil. Med. Res. 7: 4, 2020.
35. Jun, C., Y. Ling, X. Xi, P. Liu, F. Li, T. Li, Z. Shang, M. Wang, Y. Shen and H. Lu. Effectiveness study on lopinavir/ritonavir and abidol for new coronavirus pneumonia. Chin. J. Infect. Dis. 38: E008, 2020.
36. Knowles, S.R., E.J. Phillips, L. Dresser and L. Matukas. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clinical Infect. Dis. 37: 1139-1142, 2003.
37. Koren, G., S. King, S. Knowles and E. Phillips. Ribavirin in the treatment of SARS: A new trick for an old drug? CMAJ 168: 1289-1292, 2003.
38. Lansbury, L., C. Rodrigo, J. Leonardi-Bee, J. Nguyen-Van-Tam and W.S. Lim. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst. Rev. 2: Cd010406, 2019.
39. Lau, J.T., P.C. Leung, E.L. Wong, C. Fong, K.F. Cheng, S.C. Zhang, C.W. Lam, V. Wong, K.M. Choy and W.M. Ko. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: A prospective cohort study. J. Alternat. Complement. Med. 11: 49-55, 2005a.
40. Lau, T.F., P.C. Leung, E.L. Wong, C. Fong, K.F. Cheng, S.C. Zhang, C.W. Lam, V. Wong, K.M. Choy and W.M. Ko. Using herbal medicine as a means of prevention experience during the SARS crisis. Am. J. Chin. Med. 33: 345-356, 2005b.
41. Le, W. and J. Liang. The Chinese medicine system sent 2,220 people to support Hubei. Xinhua Net 2020.
42. Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G.M. Joynt, A. Ahuja, M.Y. Yung, C.B. Leung, K.F. To, S.F. Lui, C.C. Szeto, S. Chung and J.J. Sung. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348: 1986-1994, 2003.
43. Leung, P.C. The efficacy of Chinese medicine for SARS: A review of Chinese publications after the crisis. Am. J. Chin. Med. 35: 575-581, 2007.
44. Li, C., X. Zhang, S. Liu and H. Shang. Current evidence and research prospects of Xuebijing injection in treating novel coronavirus-infected pneumonia (COVID-19). Mod. Tradit. Chin. Med. Mater. Med. 22: 1-6, 2020a.
45. Li, J., X. Ma, J. Shen and Z. Zhang. Screening of active components from traditional Chinese medicine against novel coronavirus based on literature mining and molecular docking. Chin. Tradit. Herb. Drugs, 2020b, https://kns8.cnki.net/KCMS/detail/12.1108.R.20200218.1239. 008.html.
46. Li, H., S.G. Yang, L. Gu, Y. Zhang, X.X. Yan, Z.A. Liang, W. Zhang, H.Y. Jia, W. Chen, M. Liu, K.J. Yu, C.X. Xue, K. Hu, Q. Zou, L.J. Li, B. Cao and C. Wang. Effect of low-to-moderatedose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1) pdm09 viral pneumonia. Influenza Other Respir. Viruses 11: 345-354, 2017.
47. Li, Q., X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K.S.M. Leung, E.H.Y. Lau, J.Y. Wong, X. Xing, N. Xiang, Y. Wu, C. Li, Q. Chen, D. Li, T. Liu, J. Zhao, M. Li, W. Tu, C. Chen, L. Jin, R. Yang, Q. Wang, S. Zhou, R. Wang, H. Liu, Y. Luo, Y. Liu, G. Shao, H. Li, Z. Tao, Y. Yang, Z. Deng, B. Liu, Z. Ma, Y. Zhang, G. Shi, T.T.Y. Lam, J.T.K. Wu, G.F. Gao, B.J. Cowling, B. Yang, G.M. Leung and Z. Feng. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med., 2020c, doi:10.1056/ NEJMoa2001316.
48. Lipsitch, M., D.L. Swerdlow and L. Finelli. Defining the epidemiology of Covid-19 - studies needed. N. Engl. J. Med., 2020, doi:10.1056/NEJMp2002125.
49. Liu, X., M. Zhang, L. He and Y. Li. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst. Rev. 10: Cd004882, 2012.
50. Liu, Y., Y. Yang, C. Zhang, F. Huang, F. Wang, J. Yuan, Z. Wang, J. Li, J. Li, C. Feng, Z. Zhang, L. Wang, L. Peng, L. Chen, Y. Qin, D. Zhao, S. Tan, L. Yin, J. Xu, C. Zhou, C. Jiang and L. Liu. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 63: 364-374, 2020a.
51. Liu, Y.C., C.H. Liao, C.F. Chang, C.C. Chou and Y.R. Lin. A locally transmitted case of SARSCoV-2 infection in Taiwan. N. Engl. J. Med., 2020b, doi:10.1056/NEJMc2001573.
52. Lu, R., W. Wang and X. Li. Clinical observation on 63 cases of suspected cases of new coronavirus pneumonia treated by Chinese medicine Lianhua Qingwen. J. Tradit. Chin. Med., 2020a, https://kns8.cnki.net/KCMS/detail/11.2166.R.20200215.1633.004.html.
53. Lu, R., X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W.J. Liu, D. Wang, W. Xu, E.C. Holmes, G.F. Gao, G. Wu, W. Chen, W. Shi and W. Tan. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395: 565-574, 2020b.
54. Lu, Y., Z. Yang, M. Wang, J. Shi, Z. Wang, Y. Lyu, B. Tang, C. Ye, Q. Xu, K. Yin and C. Xiaorong. Analysis on Chinese medical clinical characteristics of 50 patients with 2019-nCoV-infected pneumonia. Acad. J. Shanghai Univ. Tradit. Chinese Med. 34: 1-5, 2020c.
55. Luo, H., Q.L. Tang, Y.X. Shang, S.B. Liang, M. Yang, N. Robinson and J.P. Liu. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin. J. Integr. Med., 2020, doi:10.1007/s11655-020-3192-6.
56. Ma, J., M. Chen and Y. Wang. Summary of TCM syndromes and treatment of new coronavirus (2019-nCoV) syndrome. Beijing J. Tradit. Chin. Med., 2020a, https://kns8.cnki.net/KCMS/ detail/11.5635.R.20200207.1616.002.html.
57. Ma, J., X. Huo, X. Chen, W. Zhu, M. Yao, Y. Qiao and Y. Zhang. Study on screening Chinese traditional medicine against SARS-CoV-2 based on Mpro and PLP. China J. Chin. Mater. Med., 2020b, doi:10.19540/j.cnki.cjcmm.20200216.401.
58. Marano, G., S. Vaglio, S. Pupella, G. Facco, L. Catalano, G.M. Liumbruno and G. Grazzini. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion 14: 152-157, 2016.
59. Miao, Q., X. Cong, B. Wang, Y. Wang and Z. Zhang. TCM understanding and thinking of pneumonia infected by new coronavirus. J. Tradit. Chin. Med., 2020, https://kns8.cnki.net/KCMS/ detail/11.2166.R.20200205.1606.002.html.
60. National Health Commission and National Administration of Traditional Chinese Medicine. Diagnosis and treatment of pneumonia caused by new coronavirus (trial version 6). National Health Commission, National Administration of Traditional Chinese Medicine, Beijing, 2020.
61. National Administration of Traditional Chinese Medicine. Beijing's first confirmed case of new coronavirus pneumonia cured by Symptomatic and Chinese medicine treatment National Administration of Traditional Chinese Medicine, Beijing, 2020a.
62. National Administration of Traditional Chinese Medicine. Progress in screening of effective prescriptions of traditional Chinese medicine. National Administration of Traditional Chinese Medicine, Beijing, 2020b.
63. Niu, M., R. Wang, Z. Wang, P. Zhang, Z. Bai, J. Jing, Y. Guo, X. Zhao, X. Zhan, Z. Zhang, X. Song, E. Qin, J. Wang and X. Xiao. Rapid establishment of traditional Chinese medicine prevention and treatment for the novel coronavirus pneumonia based on clinical experience and molecular docking. China J. Chin. Mater. Med., 2020, doi:10.19540/j.cnki.cjcmm.20200206.501.
64. Pan, X., D. Chen, Y. Xia, X. Wu, T. Li, X. Ou, L. Zhou and J. Liu. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect. Dis., 2020, doi:10.1016/S1473-3099(20) 30114-6.
65. Pang, W., X. Jin, B. Pang, F. Yang, H. Wang, C. Liu, W. Zheng and J. Zhang. Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of novel coronavirus pneumonia. China J. Chin. Mater. Med., 2020, doi:10.19540/j.cnki. cjcmm.20200218.502.
66. Pongpirul, W.A., K. Pongpirul, A.C. Ratnarathon and W. Prasithsirikul. Journey of a Thai taxi driver and novel coronavirus. N. Engl. J. Med., 2020, doi:10.1056/NEJMc2001621.
67. Rothe, C., M. Schunk, P. Sothmann, G. Bretzel, G. Froeschl, C. Wallrauch, T. Zimmer, V. Thiel, C. Janke, W. Guggemos, M. Seilmaier, C. Drosten, P. Vollmar, K. Zwirglmaier, S. Zange, R. Wolfel and M. Hoelscher. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 382: 970-971, 2020.
68. Russell, C.D., J.E. Millar and J.K. Baillie. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395: 473-475, 2020.
69. Sainz, B., Jr., E.C. Mossel, C.J. Peters and R.F. Garry. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329: 11-17, 2004.
70. Scagnolari, C., E. Vicenzi, F. Bellomi, M.G. Stillitano, D. Pinna, G. Poli, M. Clementi, F. Dianzani and G. Antonelli. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir. Ther. 9: 1003-1011, 2004.
71. Siemieniuk, R.A., M.O. Meade, P. Alonso-Coello, M. Briel, N. Evaniew, M. Prasad, P.E. Alexander, Y. Fei, P.O. Vandvik, M. Loeb and G.H. Guyatt. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: A systematic review and meta-analysis. Ann. Intern. Med. 163: 519-528, 2015.
72. Sood, R., G.R. Law and A.C. Ford. Diagnosis of IBS: Symptoms, symptom-based criteria, biomarkers or 'psychomarkers'? Nat. Rev. Gastroenterol. Hepatol. 11: 683-691, 2014.
73. Stockman, L.J., R. Bellamy and P. Garner. SARS: Systematic review of treatment effects. PLoS Med 3: e343, 2006.
74. Sun, K., J. Chen and C. Viboud. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: A population-level observational study. Lancet Dig. Health, 2020a, doi:10.1016/S2589-7500(20)30026-1.
75. Sun, Z., X. An, W. Xiao, C. Zhang, H. Zhang, Z. Zeng and J. Zhou. Discussion on new coronavirus infected pneumonia based on staging of differentiation and treatment. J. Shaanxi Univ. Chin. Med. 2: 2020b, https://kns8.cnki.net/KCMS/detail/61.1501.R.20200211.1318.002.html.
76. Sung, J.J., A. Wu, G.M. Joynt, K.Y. Yuen, N. Lee, P.K. Chan, C.S. Cockram, A.T. Ahuja, L.M. Yu, V.W. Wong and D.S. Hui. Severe acute respiratory syndrome: Report of treatment and outcome after a major outbreak. Thorax 59: 414-420, 2004.
77. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin. J. Epidemiol. 41: 145-151, 2020.
78. The State Council, The People's Republic of China. Latest developments in epidemic control 17 February 2020. The State Council, The People's Republic of China, 2020a.
79. The State Council, The People's Republic of China. Latest developments in epidemic control 21 February 2020.
80. The State Council, The People's Republic of China, 2020b.
81. Time and Date AS. Past Weather in Wuhan, Hubei, China. Stavanger, Norway, 2020.
82. Tong, X., X. Li, L. Zhao, Q. Li, Y. Yang, Y. Lin, Q. Ding, Y. Lei, Q. Wang, B. Song, W. Liu, S. Shen, X. Zhu, F. Huang and Y. Zhou. Discussion on traditional Chinese medicine prevention and treatment strategies of new coronavirus pneumonia (COVID-19) from the perspective of Cold and Dampness Epidemic. J. Tradit. Chin. Med., 2020, https://kns8.cnki.net/ KCMS/detail/11.2166.R.20200217.2034.006.html.
83. Tsang, K.W., P.L. Ho, G.C. Ooi, W.K. Yee, T. Wang, M. Chan-Yeung, W.K. Lam, W.H. Seto, L.Y. Yam, T.M. Cheung, P.C. Wong, B. Lam, M.S. Ip, J. Chan, K.Y. Yuen and K.N. Lai. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348: 1977-1985, 2003.
84. Tsui, P.T., M.L. Kwok, H. Yuen and S.T. Lai. Severe acute respiratory syndrome: Clinical outcome and prognostic correlates. Emerging Infect. Dis. 9: 1064-1069, 2003.
85. Van Cuong, L., H.T.N. Giang, L.K. Linh, J. Shah, L. Van Sy, T.H. Hung, A. Reda, L.N. Truong, D.X. Tien and N.T. Huy. The first Vietnamese case of COVID-19 acquired from China. Lancet Infect. Dis., 2020, doi:10.1016/S1473-3099(20)30111-0.
86. Wang, D., B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong, Y. Zhao, Y. Li, X. Wang and Z. Peng. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020a, doi:10.1001/ jama.2020.1585.
87. Wang, M., R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, Z. Shi, Z. Hu, W. Zhong and G. Xiao. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30: 269-271, 2020b.
88. Wang, X., C. Liao, Z. Li, H. Hu, X. Cheng, Q. LI and J. Lu. Preliminary analysis on the early epidemic and spatiotemporal distribution of new coronavirus pneumonia in Guangdong Province. J. Trop. Med., 2020c, https://kns8.cnki.net/KCMS/detail/44.1503.R.20200213. 0806.002.html.
89. Wang, Y., W. Qi, J. Ma, L. Ruan, Y. Lu, X. Li, X. Zhao, Z. Zhang and Q. Liu. TCM clinical features and syndrome differentiation of new coronavirus (2019-nCoV) pneumonia. J. Tradit. Chin. Med. 61: 1-7, 2020d.
90. Wang, Z. and J. Li. Wuhan's first Chinese medicine-oriented Module Hospital operates. Xinhua Net, Wuhan, 2020.
91. World Health Organisation. Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine. World Health Organisation, Geneva, 2004, pp. 1-194.
92. World Health Organisation. Coronavirus disease 2019 (COVID-19) situation report-31. World Health Organisation, Geneva, 2020a.
93. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: Interim guidance. World Health Organization, Geneva, 2020b.
94. Wrapp, D., N. Wang, K.S. Corbett, J.A. Goldsmith, C.-L. Hsieh, O. Abiona, B.S. Graham and J.S. McLellan. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science eabb2507, 2020.
95. Wu, J.T., K. Leung and G.M. Leung. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet 395: 689-697, 2020.
96. Xia, W., C. An, Y. Zheng, J. Zhang, M. Huang, Y. Wang, F. Yang, C. Duan and Z. Li. Clinical study on 34 cases of new coronavirus pneumonia treated with integrated traditional Chinese and Western medicine. J. Tradit. Chin. Med., 2020, http://kns.cnki.net/kcms/detail/11.2166.R.20200217.1502.004.html.
97. Xu, X., P. Chen, J. Wang, J. Feng, H. Zhou, X. Li, W. Zhong and P. Hao. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 63: 457-460, 2020a.
98. Xu, X., Y. Zhang, X. Li and X. Li. Analysis on prevention plan of corona virus disease-19 (COVID-19) by traditional Chinese medicine in various regions. Chin. Tradit. Herb. Drugs 51: 1-8, 2020b.
99. Xu, X.W., X.X. Wu, X.G. Jiang, K.J. Xu, L.J. Ying, C.L. Ma, S.B. Li, H.Y. Wang, S. Zhang, H.N. Gao, J.F. Sheng, H.L. Cai, Y.Q. Qiu and L.J. Li. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ 368: m606, 2020c.
100. Xu, Z., S. Li, S. Tian, H. Li and L.-q. Kong. Full spectrum of COVID-19 severity still being depicted. Lancet, 2020d, doi:10.1016/S0140-6736(20)30308-1.
101. Xu, Z., L. Shi, Y. Wang, J. Zhang, L. Huang, C. Zhang, S. Liu, P. Zhao, H. Liu, L. Zhu, Y. Tai, C. Bai, T. Gao, J. Song, P. Xia, J. Dong, J. Zhao and F.-S. Wang. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med., 2020e, doi:10.1016/S2213-2600(20)30076-X.
102. Yao, K., M. Liu, X. Li, J. Huang and H. Cai. Retrospective clinical analysis on treatment of novel coronavirus-infected pneumonia with traditional Chinese medicine Lianhua Qingwen. Chin. J. Exp. Tradit. Med. Formulae, 2020, doi:10.13422/j.cnki.syfjx.20201099.
103. Yang, W. and C. Yu. Analysis and discussion on the prevention and treatment of new pneumonia based on the theory of Five Movements and Six Qi. Chin. J. Basic Med. Traditi. Chin. Med., 2020, https://kns8.cnki.net/KCMS/detail/11.3554.r.20200207.0849.002.html.
104. Yang, H., L. Li, C. Gou, J. Zhang, X. Luo, A. Jin, X. Wang and X. Li. TCM syndrome and pathogenesis of new coronavirus pneumonia in Beijing. Beijing J. Tradit. Chin. Med., 2020a, https://kns8.cnki.net/KCMS/detail/11.5635.r.20200212.2218.002.html.
105. Yang, X., Y. Yu, J.X. Xu, H. Shu, J.a. Xia, H. Liu, Y. Wu, L. Zhang, Z. Yu, M. Fang, T. Yu, Y. Wang, S. Pan, X. Zou, S. Yuan and Y. Shang. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet, 2020b, doi:10.1016/S2213-2600(20)30079-5.
106. Yeo, C., S. Kaushal and D. Yeo. Enteric involvement of coronaviruses: Is faecal-oral transmission of SARS-CoV-2 possible?, Lancet Gastroenterol. Hepatol., 2020, doi:10.1016/S2468-1253(20) 30048-0.
107. Yong, W., C. Feng, L. Zhang, Q. Wang, Y. Liu and Z. Zhang. Analysis of 4 cases of corona virus disease-19 treated by integrated traditional Chinese and Western medicine in Gansu. Shanghai J. Tradit. Chin. Med. 54: 21-24, 2020.
108. Yu, W.C., D.S. Hui and M. Chan-Yeung. Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS). Thorax 59: 643-645, 2004.
109. Yu, M., Q. Chai, C. Liang, Y. Ding, Z. Lin, J. Gao, H. Wang, L. Zhang, J. Liu and Y. Fei. Metaanalysis of traditional Chinese medicine prevention and diagnosis and treatment plans for new coronavirus pneumonia. J. Tradit. Chin. Med., 2020a, https://kns8.cnki.net/KCMS/detail/ 11.2166.r.20200211.0848.002.html.
110. Yu, S., Y. Cui, Z. Wang, J. Jing, L. Wang, Y. Sun, M. Tian, X. Sang, W. Xu, L. Wang, E. Qin, Z. Chen, X. Xiao and R. Wang. Analysis of the relationship between clinical features and tongue manifestations of 40 cases with novel coronavirus pneumonia. Beijing J. Tradit. Chin. Med., 2020b, https://kns8.cnki.net/KCMS/detail/11.5635.R.20200215.2008.002.html.
111. Yuan, Q. and Y. Qiu. Forty-one patients with new coronavirus pneumonia were treated with traditional Chinese medicine. Xinhua Net, Shanghai, 2020.
112. Zhang, J.J., X. Dong, Y.Y. Cao, Y.D. Yuan, Y.B. Yang, Y.Q. Yan, C.A. Akdis and Y.D. Gao. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy, 2020a, doi:10.1111/all.14238.
113. Zhang, X., L. Li, G.-C. Dai, F. Ye, N.-L. Ma, Z. Feng, L. Hu, Q. Shi, Z.-Y. Zhou, H.-B. Cheng and Y.-X. Yi. A preliminary study on the clinical characteristics and Chinese medical syndrome of 42 cases of COVID-19 in Nanjing. J. Nanjing Univ. Tradit. Chin. Med., 2020b, https://kns8. cnki.net/KCMS/detail/32.1247.r.20200219.0801.002.html.
114. Zhao, J., S. Tian, J. Yang, J. Liu and W. Zhang. Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of novel coronavirus pneumonia by network pharmacology. Chin. Tradit. Herb. Drugs, 2020, http://kns.cnki.net/kcms/detail/12.1108.R.20200216.2044.002.html.
115. Zhaori, G. Antiviral treatment of SARS: Can we draw any conclusions? CMAJ 169: 1165-1166, 2003.
116. Zheng, W., J. Zhang, F. Yang, Y.L. Wang, Qingquan and Z. Boli. A review on the diagnosis and treatment guidelines of pneumonia in the prevention and treatment of new coronavirus by traditional Chinese medicine. J. Tradit. Chin. Med., 2020, https://kns8.cnki.net/KCMS/detail/ 11.2166.r.20200206.1113.002.html.
117. Zhu, N., D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, P. Niu, F. Zhan, X. Ma, D. Wang, W. Xu, G. Wu, G.F. Gao and W. Tan. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382: 727-733, 2020.
118. Zong, Y., M. Ding, K. Jia, S. Ma and W. Ju. Exploring the active compounds of Da-Yuan-Yin in treatment of novel coronavirus (2019-nCoV) pneumonia based on network pharmacology and molecular docking method. Chin. Tradit. Herb. Drugs, 2020, https://kns8.cnki.net/KCMS/ detail/12.1108.r.20200209.1038.002.html.
119. Zou, L., F. Ruan, M. Huang, L. Liang, H. Huang, Z. Hong, J. Yu, M. Kang, Y. Song, J. Xia, Q. Guo, T. Song, J. He, H.L. Yen, M. Peiris and J. Wu. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med., 2020, doi:10.1056/NEJMc2001737.